Anja Linnemann

Angestellt, Senior Director Global Field Medical Strategy, Bristol Myers Squibb

Steinhausen, Kanton Zug, Schweiz

Fähigkeiten und Kenntnisse

Matrix Leadership
Field Medical Structure & Activities
Virtual Leaderhip
Operational Management
Cultural Diversity
Clinical Trials
Cardiovascular Disorders
Factor Xa Inh./Apixaban
Metabolic Disorders
DPP4-Inh./Saxagliptin
SLGT2-Inh/Dapagliflozin
GLP-1/Exenatide
Medical Market Research
Standard Operating Procedure
Medical Excellence

Werdegang

Berufserfahrung von Anja Linnemann

  • Bis heute 1 Jahr und 2 Monate, seit Mai 2023

    Senior Director Global Field Medical Strategy

    Bristol Myers Squibb

    Leading a Field Medical Strategy Team across US, Japan and Europe and covering strategic leadership for Field Medical employees (i.e. Medical Science Liaisons, Scientific Advisors, Field Medical Managers) across all Therapeutic Areas and all regions globally.

  • 9 Jahre und 1 Monat, Mai 2014 - Mai 2023

    Global Field Medical Director

    Bristol Myers Squibb (Global Capabilities Hub)

    Leading strategic initiatives for Field Medical Teams (Medical Science Managers/Liaisons, Scientific Advisors and FM Managers) globally & across all Therapeutic Areas. Creation of procedural documents to standardize FM work. Coordination of internal/external Value Research (e.g. qualitative/quantitative HCP Research). X-functional cooperation with e.g. Commercial, Clinical Research, Regulatory, Legal & Compliance. Member of the Leadership Team: Worldwide Field Medical Excellence & Global Capability Hub.

  • 4 Jahre und 7 Monate, Okt. 2009 - Apr. 2014

    Disease Area Head, Cardiovascular & Diabetes, European Markets Region

    Bristol-Myers Squibb SA

    Strategic medical matrix leadership for the Cardiovascular and Diabetes medical team in the EUM region (16 European countries); Covered compound Cardiovascular (in cooperation with Pfizer): FactorXa/Apixaban Covered compounds Diabetes (in cooperation with AstraZeneca): DPP4-I/Saxagliptin, GLP2-I/Dapagliflozin, GLP1/Exenatide

  • 7 Monate, März 2009 - Sep. 2009

    Medical Communication Lead, Cardiovascular, EMEA Region

    Bristol-Myers Squibb SA

    Medical communication and training activities for cardiovascular products (commercialized and pipeline) for the EMEA region

  • 2 Jahre und 2 Monate, Aug. 2007 - Sep. 2009

    Medical Advisor, Cardiovascular, Switzerland

    Bristol-Myers Squibb SA

    Medical responsibility for cardiovascular products in Switzerland

  • 2 Jahre und 11 Monate, Sep. 2004 - Juli 2007

    Head of Scientific Coordination, Global

    BIOPTRON AG

    Scientific point of contact for external (physicians, payors, health authorities, vendors) and internal (crossfunctional deparments) customers; Interface between research and marketing; Global medical information and training responsibility; Safety officer according European MEDDEV guidelines;

  • 3 Jahre und 11 Monate, Okt. 2000 - Aug. 2004

    Scientific Coordinator, International

    BIOPTRON AG

    Scientific point of contact for external (physicians, payors, health authorities, vendors) and internal (crossfunctional deparments) customers; Interface between research and marketing;

  • 1 Jahr und 9 Monate, Sep. 1998 - Mai 2000

    Wissenschaftliche Mitarbeiterin

    Universität Hohenheim
  • 1993 - 2000

    PTA

    Landesapothekerverband Stuttgart

Ausbildung von Anja Linnemann

  • 1993 - 2000

    Biologie

    Universität Hohenheim, Deutschland

    Biotechnologie, Mikrobiologie, Virologie, Biochemie, Physiologie

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Französisch

    Gut

Interessen

Fremde Länder und Kulturen
Natur und Berge
Kulturelles und Kulinarisches

21 Mio. XING Mitglieder, von A bis Z